Hisaki Aiba Hiroaki Kimura Satoshi Yamada Hideki Okamoto Katsuhiro Hayashi Shinji Miwa Yohei Kawaguchi Shiro Saito Takao Sakai Tsutomu Tatematsu Ryoichi Nakanishi Hideki Murakami
10.1371/journal.pone.0254866
PLoS One
2021 Jul 16;16(7):e0254866.
CC BY
https://pubmed.ncbi.nlm.nih.gov/34270626/
Antineoplastic Combined Chemotherapy Protocols / adverse effects Indazoles / adverse effects Lung Neoplasms / drug therapy Pneumothorax / epidemiology Pyrimidines / adverse effects Soft Tissue Neoplasms / drug therapy Sulfonamides / adverse effects
Antineoplastic Combined Chemotherapy Protocols / adverse effects Indazoles / adverse effects Lung Neoplasms / drug therapy Pneumothorax / epidemiology Pyrimidines / adverse effects Soft Tissue Neoplasms / drug therapy Sulfonamides / adverse effects Adult Aged Antineoplastic Combined Chemotherapy Protocols / administration & dosage Dose-Response Relationship, Drug Drug Administration Schedule Female Humans Incidence Indazoles / administration & dosage Lung / drug effects Lung / pathology Lung Neoplasms / secondary Male Middle Aged Pleura / drug effects Pleura / pathology Pneumothorax / chemically induced Pneumothorax / diagnosis Pneumothorax / pathology Pyrimidines / administration & dosage Retrospective Studies Risk Assessment / statistics & numerical data Risk Factors Soft Tissue Neoplasms / pathology Sulfonamides / administration & dosage Time Factors Indazoles Pyrimidines Sulfonamides pazopanib
PMC8284672
34270626
Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis
2021